Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe

Lung Cancer

Volumn 31, Issue 2-3, 2001, Pages 123-137

  Janssen Heijnen, Maryska L G ^a   Coebergh, Jan Willem W ^a,b  

^a Eindhoven Cancer Registry   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Histology; Incidence; Lung cancer; Mortality; Prognosis; Trends

Indexed keywords

TAR;

AGE; ARTICLE; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CIGARETTE SMOKING; COHORT ANALYSIS; COMPUTER; DATA BASE; EUROPE; FEMALE; HISTOLOGY; HUMAN; INDUSTRIALIZATION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MEDICAL LITERATURE; NEW ZEALAND; NORTH AMERICA; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUSTRALIA; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; EUROPE; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; NEW ZEALAND; NORTH AMERICA; PROGNOSIS; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 0035141819     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00197-5     Document Type: Article

References (162)

1. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
2. Cancer incidence and mortality trends among whites in the United States, 1947-84
3. Cancer incidence in New South Wales, Australia
4. Trends of cancer mortality in Europe, 1955-1989: II, respiratory tract, bone, connective and soft tissue sarcomas, and skin
5. The World Health Organization histological typing of lung tumours
6. Bronchoalveolar carcinoma: factors affecting survival
7. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features
8. Epidemiology of bronchioloalveolar carcinoma
9. The Will Rogers' phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
10. Falling rates of lung cancer in men in the United States
11. The changing incidence of cancer in adults in New South Wales
12. Exploring time trends in cancer incidence
13. Incidence of lung cancer in Denmark: historical and actual status
14. Trends in cancer mortality, 1955-1989: Asia, Africa and Oceania
15. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989
16. Striking changes in smoking behaviour and lung cancer incidence by histological type in the south-east Netherlands, 1960-1991
17. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females
18. Lung carcinoma trends by histologic type in Vaud and Neuchâtel, Switzerland, 1974-1994
19. Changes in lung cancer histological types in Varese Cancer Registry, Italy 1976-1992
20. Cigarette smoking and changes in the histopathology of lung cancer
21. Cancer incidence registration and trends in Ontario
22. Declining lung cancer rates among young men and women in the United States: a cohort analysis
23. The changing histopathology of lung cancer: a review of 1682 cases
24. A population-based study of lung cancer incidence trends by histologic type, 1974-81
25. Secular trends in histologic types of lung cancer
26. Significant changes in the distribution of histologic types of lung cancer: a review of 4928 cases
27. The aetiology of lung cancer
28. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma
29. Smoking and carcinoma of the lung: preliminary report
30. Mortality in relation to smoking: 20 years' observation on male British doctors
31. Tobacco as a cause of lung cancer: some reflections
32. Assessment of lung cancer risk factors by histologic category
33. Modifying risk of developing lung cancer by changing habits of cigarette smoking
34. Cohort analysis of cigarette smoking and lung cancer incidence among Norwegian women
35. Mortality in relation to smoking: 40 years' observations on male British doctors
36. Preferential formation of Benzo[a]pyrene adducts at lung cancer mutational hotspots in P53
37. Determinants of cell type in patients with cancer of the lungs
38. Effect of tobacco smoking on various histological types of lung cancer
39. Variation in smoking-related lung cancer risk factors by cell type among men in Argentina: a case-control study
40. Uninary nicotine metabolite excretion and lung cancer risk in a female cohort
41. Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study
42. Urinary cotinine and lung cancer risk in a female cohort
43. The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women
44. Cigarette smoking and lung cancer cell types
45. Reduction in risk of lung cancer among ex-smokers with particular reference to histologic type
46. Smoking and lung cancer: scientific challenges and opportunities
47. Lung cancer among cigar and pipe smokers
48. Lung cancer risk is proportional to cigarette tar yield: evidence from a prospective study
49. Air pollution as a risk factor in lung cancer
50. The interactions of tobacco smoking and other agents in cancer etiology
51. Relationship between occupation and lung cancer as analyzed by age and histologic type
52. Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph?
53. Interactions between people's diet and their smoking habits: the dietary and nutritional survey of British adults
54. A prospective cohort study on Allium vegetable consumption, garlic supplement use and the risk of lung carcinoma in The Netherlands
55. Relationship of serum cholesterol, dietary and plasma β-carotene with lung cancer in male smokers
56. The association between fruit and vegetable intake and chronic disease risk factors
57. Importance of α-Carotene, β-Carotene, and other phytochemicals in the etiology of lung cancer
58. Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies
59. For debate: pet birds as an independent risk factor for lung cancer
60. Avian exposure and bronchogenic carcinoma
61. Pet birds as an independent risk factor for lung cancer: case-control study
62. Avian exposure and risk of lung cancer in women in Missouri: population based case control study
63. Pet birds and risk of lung cancer in Sweden: a case-control study
64. Parakeets, canaries, finches, parrots and lung cancer: no association
65. Personal and family history of respiratory disease and lung cancer risk
66. Higher risk of lung cancer in chronic obstructive pulmonary disease: a prospective, matched, controlled study
67. Airways obstruction and the risk for lung cancer
68. Preexisting lung disease and lung cancer among nonsmoking women
69. Cancer surveillance series: changing geographic patterns of lung cancer mortality in the United States, 1950 through 1994
70. Projections of lung cancer mortality in the United States: 1985-2025
71. Trends in cigarette smoking in the United States: the changing influence of gender and race
72. Trends in smoking in Europe
73. The changing epidemiology of smoking and lung cancer histology
74. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking
75. Epidemiology of tobacco use and dependence
76. The decline of smoking among Swedish men
77. Fifty-year trend in incidence rates of bronchogenic carcinoma by cell type in Olmsted County, Minnesota
78. Is the incidence of primary adenocarcinoma of the lung increasing?
79. Incidence of lung cancer by cell type: a population-based study in New Hampshire and Vermont
80. The value of the 1981 WHO histological classification in inter-observer reproducibility and changing pattern of lung cancer
81. Lung cancer in nonsmoking women: histology and survival patterns
82. Epidemiologic patterns in lung cancer by histologic type
83. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke
84. Do morphology and stage explain the inferior lung cancer survival in Denmark?
85. Variation in survival of patients with lung cancer in Europe, 1985-1989
86. Survival for lung cancer in northern Italy
87. Survival analysis of untreated patients with non-small-cell lung cancer
88. Divergent changes in survival for histological types of non-small-cell lung cancer in southeastern Netherlands since 1975
89. National survey of the pattern of care for carcinoma of the lung
90. Prognostic factors in lung cancer based on multivariate analysis
91. Lung cancer
92. Incident lung cancer survival: long term follow-up of a population-based study in Italy
93. Trends in cancer survival in Vaud, Switzerland
94. Time trends of lung and larynx cancers in Italy
95. Patterns of care and survival in non-small cell lung cancer: 15 years' experience in a general hospital
96. Survival in lung cancer: an analysis of the effects of age, sex, resectability, and histopathologic type
97. The natural five-year course in bronchial carcinoma: epidemiologic results
98. Patients presenting with lung cancer in South East Scotland
99. Age and prognosis of non-small cell lung cancer: usefulness of a relative survival model
100. Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France
101. Improvement and plateau in survival of small cell lung cancer since 1975: a population-based study
102. Analysis of long-term survivors with small-cell lung cancer
103. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years: an analysis of 1,714 consecutive patients
104. Lung cancer
105. Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983
106. Lung cancer: histological aspects of diagnosis in England and the south east Netherlands
107. Small cell carcinoma of the lung: a progress report of 15 years' experience
108. Long-term survival in small-cell carcinoma of the lung: a population experience
109. The effect of surgical treatment on survival from early lung cancer: implications for screening
110. Current status of surgical resection for lung cancer
111. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands
112. Resection rates and postoperative mortality in 7,899 patients with lung cancer
113. Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-1986
114. European school of oncology first Euro-American forum on lung cancer treatment
115. Is lung cancer resection justified in patients aged over 70 years?
116. Surgical treatment of lung cancer in the octogenarian
117. Current treatment of unresectable lung cancer
118. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung
119. K-ras oncogene activation in adenocarcinoma of the lung: incidence and relation to smoking
120. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas
121. Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study
122. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
123. The prognostic application of cytokeratin typing of nonsmall cell lung carcinoma: a retrospective study
124. Microalbuminuria in patients with lung cancer
125. On classifying cancers while treating patients
126. Cancer staging may have different meanings in academic and community hospitals
127. Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis
128. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer
129. Characteristics of lung cancer in elderly patients
130. The influence of patient age on the diagnosis and treatment of lung and colorectal cancer
131. Cancer in the elderly: meeting the challenge of an aging population
132. Cardiovascular comorbidity in the older cancer patient
133. Modern thirty day operative mortality for surgical resections in lung cancer
134. Complications of surgery in the treatment of carcinoma of the lung
135. Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients
136. Prognosis in severe chronic obstructive pulmonary disease
137. Prognosis after myocardial infarction: results of 15 year follow up
138. A clinical-severity staging system for patients with lung cancer
139. The effect of comorbidity on 3-year survival of women with primary breast cancer
140. Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease
141. Determinants of survival in older cancer patients
142. Small cell lung cancer 1973-1983: early progress and recent obstacles
143. Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer
144. Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means?
145. Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group Study
146. Long term survival of small cell lung cancer patients after chemotherapy
147. Longevity in small cell lung cancer: a report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research
148. Effect of thoracic radiotherapy on mortality in limited small cell lung cancer: a meta-analysis of 13 randomized trials among 2,140 patients
149. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation: data on potential cures, chronic toxicities, and late relapses after a five- to eleven year follow-up
150. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung
151. A meta-analysis of thoracic radiotherapy for small-cell lung cancer
152. Predictors of 5-year survival and curability in small cell lung cancer
153. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation
154. Prognosis at presentation of small cell carcinoma of the lung
155. Small cell lung carcinoma in the elderly
156. Treatment of small cell lung cancer in the elderly
157. Influence of age on the treatment of limited-stage small-cell lung cancer